Clinical Trials

Accrual Status
Limit to SWOG Trials

1052 Results

    View
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    S2506

    MOZART MZL: A Randomized Phase II Study with a Common Control Arm of Mosunetuzumab Monotherapy Evaluated Against Two Experimental Treatment Arms of Either Combination Mosunetuzumab and Zanubrutinib or Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients with Relapsed/Refractory Marginal Zone Lymphoma
    Status Notes
    Effective 08/18/2026, S2506 is open to accrual.
    Research Committee(s)
    Lymphoma
    Activated
    08-18-2026
    ClinicalTrials.gov Registry Number
    07638722
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    S1900N

    A Randomized Phase II Study of Sacituzumab Govitecan alone, Ivonescimab alone, or Sacituzumab Govitecan and Ivonescimab in Participants with Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)
    Status Notes
    The above-referenced study will be open to participant accrual, effective 12:00 p.m. Pacific Time on August 3, 2026.
    Research Committee(s)
    LungMAP
    Activated
    08-03-2026
    ClinicalTrials.gov Registry Number
    07393555
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    MM1OA-S04

    A Phase 2 trial of ASTX727 with standard duration versus shorter duration of venetoclax in genomically heterogenous AML among adults aged 60 or older and less fit for intensive therapy: a myeloMATCH substudy.
    Research Committee(s)
    myeloMATCH
    Activated
    07-22-2026
    ClinicalTrials.gov Registry Number
    NCT07437950
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    S2505

    Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma
    Status Notes
    Effective 7/6/2026 S2505 is active.
    Research Committee(s)
    Early Therapeutics & Rare Cancers
    Activated
    07-06-2026
    ClinicalTrials.gov Registry Number
    07615049
    Open
    Phase
    Accrual
    1%
    SWOG Clinical Trial Number
    S2504

    A Randomized Phase III Study of PIRtobrutinib plus R-CHOP vs. R-CHOP for Patients with Previously UntreateD RIchter TrAnsforMation (RT) (pirAMID)
    Status Notes
    Study is active as of 06/01/2026.
    Research Committee(s)
    Leukemia
    Lymphoma
    Activated
    06-01-2026
    ClinicalTrials.gov Registry Number
    07220187
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    S2424CD

    A Randomized Controlled Trial of an Intervention called Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT) to Improve Goals of Care Communication for People with Cancer
    Status Notes
    Activation 06/01/2026
    Research Committee(s)
    Cancer Care Delivery
    Activated
    06-01-2026
    ClinicalTrials.gov Registry Number
    07278739